The interpretation of CHA2DS2-VA score components in clinical practice: Data from Türkiye
Pamukkale Medical Journal · 10.07.2026 · 19 (3) · 547-557
DOI: 10.31362/patd.1790457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pamukkale Medical Journal, online erschienen am 10.07.2026. Verfasst von Emrah Kaya und 4 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Purpose
Atrial fibrillation (AF) is associated with an increased risk of stroke, necessitating accurate risk stratification using validated tools such as the CHA2DS2-VA score. Despite its widespread use, variability exists in clinicians’ interpretation and application of its components. To assess the understanding, interpretation, and practical application of the “C” (congestive heart failure/left ventricular systolic dysfunction), “H” (hypertension), “D” (diabetes mellitus), and “V” (vascular disease) components of the CHA2DS2-VA score among clinicians in Türkiye, and to identify potential educational and informational needs.Materials and methods: Between July 15 and September 15, 2025, an online survey consisting of 10 multiple-choice questions was administered to physicians via WhatsApp. A total of 197 complete responses were analyzed. The survey assessed knowledge of component definitions, scoring practices, ease of application, and resources used for calculation.
Results
Recognition was highest for the “D” criterion, while the “H” component showed moderate agreement. The “C” and particularly the “V” components demonstrated greater heterogeneity, including under-recognition of aortic aneurysm and misclassification of angina pectoris and varicose veins. Clinicians primarily relied on memory (46.7%) or online resources (38.6%), with 26.9% using web-based or mobile applications. Scoring ease varied, with the “V” criterion rated as most difficult.
Conclusion
Clinicians are generally familiar with the CHA2DS2-VA score, but interpretation of heart failure and vascular disease components is inconsistent. Targeted education, clearer operational definitions, and integration of validated risk calculators into electronic health records and mobile platforms may improve scoring accuracy, consistency, and stroke risk assessment in AF patients.
Zitieren
APA
Kaya, E., Batak, C. N., Güngör, B., Uzun, M. H., & Astarcıoglu, M. A. (2026). The interpretation of CHA2DS2-VA score components in clinical practice: Data from Türkiye. Pamukkale Medical Journal, 19(3), 547-557. https://doi.org/10.31362/patd.1790457
Vancouver
Kaya E, Batak CN, Güngör B, Uzun MH, Astarcıoglu MA. The interpretation of CHA2DS2-VA score components in clinical practice: Data from Türkiye. Pamukkale Medical Journal. 2026;19(3):547-557. doi:10.31362/patd.1790457
BibTeX
@article{Kaya2026,
author = {Kaya, Emrah and Batak, Ceyda Nur and Güngör, Burak and Uzun, Mehmet Hakan and Astarcıoglu, Mehmet Ali},
title = {The interpretation of CHA2DS2-VA score components in clinical practice: Data from Türkiye},
journal = {Pamukkale Medical Journal},
year = {2026},
volume = {19},
number = {3},
pages = {547--557},
doi = {10.31362/patd.1790457}
}
EUVIMED